 |
 |
 |
 |
 |
 |
 |
 |
Efavirenz (Sustiva, Stocrin)
Overview
- A Clinical Overview of Efavirenz (Sustiva, Stocrin) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Prescribing Information for Efavirenz (Sustiva, Stocrin) (PDF) (March 2008)
From Bristol-Myers Squibb Company - Important Update to Sustiva Package Insert (January 31, 2007)
From U.S. Food and Drug Administration - Drug Interactions: Efavirenz (August 2004)
From Project Inform - Does Viramune = Sustiva? (May/June 2003)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
News
- Important Update to Sustiva Package Insert (January 31, 2007)
From U.S. Food and Drug Administration - Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
From U.S. Food and Drug Administration - Efavirenz, Stavudine Demand May Soon Exceed Supply in Developing World (March 4, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - FDA Approves Once-Daily Efavirenz Formulation, Revised Labeling (March 8, 2002)
In AIDS Treatment News, from AIDS Treatment News - Sustiva Seems to Cause Prisoners to Wrongly Test Positive for Marijuana Use (November/December 2001)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network - Nelfinavir, Efavirenz, or Both After the Failure of Nucleoside Treatment of HIV Infection (August 9, 2001)
In New England Journal of Medicine
Clinical Management
Clinical Management
  |
  |